Not medical advice. SNAP-8 is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.
SNAP-8 (Acetyl Octapeptide-3) is an extended eight-amino-acid analog of Argireline that provides roughly 30% greater SNARE inhibition for topical expression-line research, reaching up to 63% wrinkle depth reduction at 10% formulation in clinical studies.
One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.
SNAP-8 (Acetyl Octapeptide-3) competitively inhibits SNARE complex assembly by mimicking SNAP-25 N-terminus, reducing neuromuscular exocytosis.
Peer-reviewed literature typically discusses SNAP-8 in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.
Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.
This group is commonly explored in dermatology-style research: collagen-related pathways, extracellular matrix, and how skin-supporting cells respond after stress or ageing-related change in lab settings.
Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.
Storage requirements: Lyophilised: 2–8 °C. Stable in aqueous solution at pH 4–6. · Learn best practices in our detailed storage guide.
Research dosing context: Literature typically discusses 3–10% SNAP-8 solution in topical formulation · Twice daily topical application to expression line areas · Hydrophilic peptide (MW 1075.24 Da) with limited passive stratum corneum permeation, dissolving microneedle delivery improves penetration up to 40-fold versus passive application. Optimal results at 10% solution concentration in clinical studies. Effects are cumulative over 28-day treatment course. Mechanism is entirely reversible upon discontinuation, effects diminish gradually. For enhanced delivery, formulate with penetration enhancers or microneedle systems.
Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.
SNAP-8 (INCI name Acetyl Octapeptide-3, Ac-EEMQRRAD-NH₂) is an eight-amino-acid topical cosmetic peptide that mimics the N-terminus of the protein SNAP-25. By competing with native SNAP-25 during SNARE-complex assembly, it gently and reversibly reduces acetylcholine release at the neuromuscular junction, softening the repeated micro-contractions that etch dynamic expression lines into skin. New-U supplies it for laboratory and cosmetic-formulation research.
The mechanism (competitive SNARE inhibition) is well described, and SNAP-8 is a popular cosmetic active. The headline numbers - about 30% stronger SNARE inhibition than Argireline and up to 63% wrinkle-depth reduction at 10% over 28 days - come mainly from the manufacturer's own efficacy testing rather than large independent peer-reviewed trials, so treat them as sponsor-reported. Peer-reviewed literature specific to SNAP-8 is thin compared with injectable neuromodulators.
Same mechanism, slightly longer peptide. Argireline is a six-residue hexapeptide (Ac-EEMQRR-NH₂); SNAP-8 is the same sequence with two extra residues (Ala-Asp) added at the C-terminus. The extra residues extend the binding interface for competitive SNARE inhibition, which the manufacturer associates with roughly 30% greater SNARE blockade in comparative assays.
It is a topical-only active - it is not formulated or intended for injection. Cosmetic studies describe use levels around 3-10% in a finished leave-on formulation, applied twice daily, with effects that build cumulatively over a multi-week course. Because the peptide is hydrophilic, stratum-corneum penetration is the main limitation, so penetration enhancers, liposomes or microneedle delivery are studied to improve uptake. This is descriptive formulation context, not a usage recommendation.
They work on different pathways and are frequently combined rather than substituted. SNAP-8 (like Argireline) targets muscle-driven dynamic lines via the SNARE pathway, while Matrixyl (a signal peptide) and copper peptides (GHK-Cu) target collagen synthesis and extracellular-matrix remodelling. A multi-pathway formulation pairs a SNARE peptide with a collagen-signalling peptide to address both wrinkle types.
Not really. Both SNAP-8 and botulinum toxin converge on the SNARE complex, but the mechanisms are very different. Botulinum toxin is an enzyme that cleaves SNAP-25 irreversibly; SNAP-8 is a short peptide mimic that competes with SNAP-25 reversibly. The effect is far milder, far more reversible, and far less potent than an actual neurotoxin.
Store the lyophilised powder refrigerated at 2-8 °C. In formulated topical products it is stable in aqueous solution at pH 4-6. Penetration remains the main limitation - dissolving microneedle delivery, liposomes, or other penetration enhancers can improve stratum-corneum crossing significantly.
No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.
Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.
Other compounds researchers often read about alongside SNAP-8.
Primary literature and registries for SNAP-8, plus mainstream coverage of the peptide category. Research use only - not medical advice.
Databases & literature:
Peptides in the news:
Access concentration, batch info, variants, and current pricing on our shop.
Also known as: SNAP-8, Acetyl Octapeptide-3, Acetyl Glutamyl Heptapeptide-1, SNAP-25 Fragment, Ac-EEMQRRAD-NH₂, Lipotec SNAP-8